CD226 and neoplasm: Additional evidences demonstrated that CD155 expression inhibited anti-tumor activity of tumor cells in DNAM-1-deficient mice, and over-expression of CD155 resulted in tumor rejection of/by NK cells, which was mediated by DNAM-1 [20, 21].